seven-year follow-up of valoctocogene roxaparvovec gene therapy for haemophilia
Published 3 months ago • 38 plays • Length 5:26Download video MP4
Download video MP3
Similar videos
-
5:08
valoctocogene roxaparvovec gene transfer for severe haemophilia a on health-related quality of life
-
3:58
follow-up of patients with hemophilia b treated with fidanacogene elaparvovec aav gene therapy
-
1:45
safety of valoctocogene roxaparvovec for patients with hemophilia a and hiv infection
-
3:54
gener8-1 two-year analysis as presented at eahad
-
5:00
valoctocogene roxaparvovec aav gene transfer for severe hemophilia: results from phase 3 trial
-
3:57
using the world federation of haemophilia gene therapy registry
-
23:28
gene therapy for treatment of hemophilia: an introduction to aav vector gene transfer
-
4:39
a post hoc analysis of the gener8 1 phase 3 trial
-
20:34
gene therapy for treatment of hemophilia: aav vector gene therapy application to hemophilia
-
50:28
medicine for members: gene therapy for haemophilia
-
1:09:16
preparing for practice readiness in gene therapy for hemophilia
-
2:17
one year follow-up of patients with hemophilia b following spk-9001 gene transfer
-
32:25
a history of hemophilia treatment factor replacement to gene therapy
-
36:32
gene therapy for fviii
-
18:10
gene therapy for hemophilia
-
5:34
steven pipe: etranacogene dezaparvovec gene therapy for hemophilia b
-
27:50
a history of hemophilia treatment non replacement therapy to gene therapy
-
3:07
aav-based gene therapy in hemophilia a and b: valoctocogene roxaparvovec & etranacogene dezaparvovec
-
41:04
gene therapy: getting up to speed